NEONATAL GRAVES’ DISEASE
AN UNUSUAL METABOLIC AND CARDIAC ASSOCIATION FROM PRESENTATION TO RESOLUTION
Keywords:
Nenonata's Grave's diseaseAbstract
INTRODUCTION
Neonatal Graves’ disease is a rare disorder seen in 1 in 25000 births, caused by transplacental passage of TSH receptor antibody. Despite serious potential multisystem complications, it can be transient.
METHODOLOGY
We describe a newborn born to a mother with undiagnosed Graves' disease.
RESULTS
A male neonate was born prematurely at 31-weeks gestation via emergency lower segment caesarean for fetal distress with a birth weight of 1.7 kg. He was admitted to the neonatal intensive care unit due to respiratory distress requiring non-invasive ventilation. Newborn examination revealed hepatosplenomegaly with conjugated hyperbilirubinemia, hence, he was empirically treated for congenital infections. At 72 hours, the patient developed tachycardia and further work up resulted in suppressed cTSH. At that time mother was incidentally noted to have features of clinical Graves' disease which was confirmed by 2 thyroid function tests and positive TSH receptor antibody. Further radiological assessment of the newborn revealed periportal fibrosis and pulmonary hypertension. He was commenced on carbimazole and short course of prednisolone which resulted in resolution of hyperthyroidism, pulmonary hypertension, periportal fibrosis and thrombocytopenia.
CONCLUSION
Pulmonary hypertension and periportal fibrosis are rare clinical manifestations of neonatal Graves' disease which
are reversible with resolution of hyperthyroidism.
Downloads
References
*
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Puvanesvaran Ramachandran, Arini Nuran Idris, Tee Pian Pian, Farah Inaz, Lilian Ngo Ping Ling, Amelia Alias, Kam Choy Chen, Lim Poi Giok
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.